Theralink Technologies, Inc. (THER)

Market Cap	6.15K
Revenue (ttm)	635.45K
Net Income (ttm)	-13.50M
Shares Out	6.15B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,254,766
Average Volume	1,079,828
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0001 - 0.0023
Beta	20.37
RSI	34.06
Earnings Date	Jan 3, 2025

About Theralink Technologies

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying...

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: THER

Financial Performance

In 2023, Theralink Technologies's revenue was $606,796, an increase of 6.85% compared to the previous year's $567,905. Losses were -$30.95 million, 138.4% more than in 2022.